You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Met (c-Met) (phospho Y1234) antibody (ab47402)

Submit an Abreview Q&A (1)

Overview

  • Product nameAnti-Met (c-Met) (phospho Y1234) antibodySee all Met (c-Met) primary antibodies ...
  • Description
    Rabbit polyclonal to Met (c-Met) (phospho Y1234)
  • SpecificityThis antibody is specific for Met (c-Met), only when phosphorylated at tyrosine 1234.
  • Tested applicationsWB, ELISA more details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    A synthesized phosphopeptide derived from human Met (c-Met) around the phosphorylation site of tyrosine 1234 (K-E-YP-Y-S)

  • Positive controlWB: Extract from HepG2 cells

Properties

Applications

Our Abpromise guarantee covers the use of ab47402 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/500 - 1/1000. Detects a band of approximately 135 kDa (predicted molecular weight: 156 kDa).
ELISA ELISA: 1/10000.

Target

  • FunctionReceptor for hepatocyte growth factor and scatter factor. Has a tyrosine-protein kinase activity. Functions in cell proliferation, scattering, morphogenesis and survival.
  • Involvement in diseaseNote=Activation of MET after rearrangement with the TPR gene produces an oncogenic protein.
    Note=Defects in MET may be associated with gastric cancer.
    Defects in MET are a cause of hepatocellular carcinoma (HCC) [MIM:114550].
    Defects in MET are a cause of renal cell carcinoma papillary (RCCP) [MIM:605074]. It is a subtype of renal cell carcinoma tending to show a tubulo-papillary architecture formed by numerous, irregular, finger-like projections of connective tissue. Renal cell carcinoma is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. It is subclassified into common renal cell carcinoma (clear cell, non-papillary carcinoma), papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma with medullary carcinoma of the kidney, and unclassified renal cell carcinoma.
    Note=A common allele in the promoter region of the MET shows genetic association with susceptibility to autism in some families. Functional assays indicate a decrease in MET promoter activity and altered binding of specific transcription factor complexes.
    Note=MET activating mutations may be involved in the development of a highly malignant, metastatic syndrome known as cancer of unknown primary origin (CUP) or primary occult malignancy. Systemic neoplastic spread is generally a late event in cancer progression. However, in some instances, distant dissemination arises at a very early stage, so that metastases reach clinical relevance before primary lesions. Sometimes, the primary lesions cannot be identified in spite of the progresses in the diagnosis of malignancies.
  • Sequence similaritiesBelongs to the protein kinase superfamily. Tyr protein kinase family.
    Contains 3 IPT/TIG domains.
    Contains 1 protein kinase domain.
    Contains 1 Sema domain.
  • DomainThe kinase domain is involved in SPSB1 binding.
  • Post-translational
    modifications    Dephosphorylated by PTPRJ at Tyr-1349 and Tyr-1365.
  • Cellular localizationMembrane.

    • Target information above from: UniProt accession P08581 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
    see all
  • Alternative names
      AUTS9 antibodyc met antibodyD249 antibody
      Hepatocyte growth factor receptor antibodyHGF antibodyHGF receptor antibodyHGF/SF receptor antibodyHGFR antibodyMET antibodyMet proto oncogene tyrosine kinase antibodyMet proto-oncogene (hepatocyte growth factor receptor) antibodyMet proto-oncogene antibodyMet protooncogene antibodyMET_HUMAN antibodyOncogene MET antibodyPar4 antibodyProto-oncogene c-Met antibodyRCCP2 antibodyScatter factor receptor antibodySF receptor antibodyTyrosine-protein kinase Met antibody
    see all

Anti-Met (c-Met) (phospho Y1234) antibody images

  • Western blot - Met (c-Met) (phospho Y1234) antibody (ab47402)
    Western blot - Met (c-Met) (phospho Y1234) antibody (ab47402)
    All lanes : Anti-Met (c-Met) (phospho Y1234) antibody (ab47402) at 1/500 dilution

    Lane 1 : Extracts from HepG2 cells, untreated
    Lane 2 : Extracts from HepG2 cells, treated with phosphopeptide


    Predicted band size : 156 kDa

References for Anti-Met (c-Met) (phospho Y1234) antibody (ab47402)

ab47402 has not yet been referenced specifically in any publications.

Publishing research using ab47402 ? Please let us know so that we can cite the reference in this datasheet

Product Wall

Submit an Abreview for ab47402 Submit a Question for ab47402

Displaying 1 - 1 of 1 results for Abreviews and Q&A

10
Votes: Highest First

Do your antibodies against phospho-met recognize other activated tyrosine kinases e.g. EGFR, IGF-1R?

Thank you for your enquiry. I can confirm that this antibody (ab470402) will not react with any phosphorylation sites of EGFR and IGF1R and will not react with any non-phospho proteins. I hope this information is helpful. Should you have any furthe...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"